Michael V. Rocco, MD, MS; Diane L. Frankenfield, DrPH; Sari D. Hopson, MSPH; William M. McClellan, MD, MPH
Disclaimer: The views expressed in this manuscript are those of the authors and do not necessarily reflect official policy of the Centers for Medicare & Medicaid Services.
Acknowledgments: This report is dedicated to the more than 270 000 patients receiving dialysis in the United States who inspired the authors to improve their understanding of dialysis. The ESRD Clinical Performance Measures Project and the U.S. Renal Data System (USRDS) have supplied the data reported in this study. The authors thank the numerous ESRD facilities and ESRD Network personnel whose diligence and conscientious efforts resulted in the success of the ESRD Clinical Performance Measures Project. They also thank Greg Russell for his expertise with SAS graphics and Laura Furr for her secretarial assistance.
Grant Support: None.
Potential Financial Conflicts of Interest:Honoraria: M.V. Rocco (Amgen, NxStage), W.M. McClellan (Amgen, Ortho Biotech, Roche).
Requests for Single Reprints: Michael V. Rocco, MD, MS, Section on Nephrology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1053; e-mail, email@example.com.
Current Author Addresses: Dr. Rocco: Section on Nephrology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1053.
Dr. Frankenfield: Centers for Medicare & Medicaid Services, Office of Clinical Standards and Quality, 7500 Security Boulevard, Mailstop S3-02-01, Baltimore, MD 21244.
Ms. Hopson and Dr. McClellan: Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322.
Rocco MV, Frankenfield DL, Hopson SD, McClellan WM. Relationship between Clinical Performance Measures and Outcomes among Patients Receiving Long-Term Hemodialysis. Ann Intern Med. 2006;145:512-519. doi: 10.7326/0003-4819-145-7-200610030-00009
Download citation file:
Published: Ann Intern Med. 2006;145(7):512-519.
Mortality rates among patients with end-stage renal disease (ESRD) in the United States have declined during the past 2 decades despite increases in the age and prevalence of diabetes in this population (1). The improvements in survival are not uniformly distributed across patients with differing durations of long-term dialysis therapy. Mortality rates have declined by 22% during the first 2 years after renal replacement therapy and by 15% during the next 3 years and have actually increased for patients surviving longer than 5 years (1). Despite these improvements in early survival, mortality rates remain quite high among patients with ESRD who are receiving hemodialysis, and 212 of every 1000 patients die annually.
Learn more about subscription options.
Register Now for a free account.
Nephrology, Renal Replacement Therapy.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only